Abstract: OBJECTIVES: The purpose of the present study was to test whether the cumulative knowledge from the field of transapical transcatheter aortic valve implantation, when incorporated into a structured training and then gradually dispersed by internal proctoring, might eliminate the negative effect of the learning curve on the clinical outcomes. METHODS: The present study was a retrospective, singlecenter, observational cohort study of prospectively collected data from all 500 consecutive high-risk patients undergoing transapical transcatheter aortic valve implantation at our institution from April 2008 to December 2011. Of the 500 patients, 28 were in cardiogenic shock. Differences during the study period in baseline characteristics, procedural and postprocedural variables, and survival were analyzed using different statistical methods, including cumulative sum charts. RESULTS: The overall 30-day mortality was 4.6% (95% confidence interval, 3.1%-6.8%) and was 4.0% (95% confidence interval, 2.6%-6.2%) for patients without cardiogenic shock. Throughout the study period, no significant change was seen in the 30-day mortality (Mann-Whitney U test, P = .23; logistic regression analysis, odds ratio, 0.83 per 100 patients; 95% confidence interval, 0.62-1.12; P = .23). Also, no difference was seen in survival when stratified by surgeon (30-day mortality, P = .92). An insignificant change was seen toward improved overall survival (hazard ratio, 0.90 per 100 patients; 95% confidence interval, 0.77-1.04; P = .15). CONCLUSIONS: The structured training program can be used to introduce transapical transcatheter aortic valve implantation and then gradually dispersed by internal proctoring to other members of the team with no concomitant detriment to patients. 
Objectives: The purpose of the present study was to test whether the cumulative knowledge from the field of transapical transcatheter aortic valve implantation, when incorporated into a structured training and then gradually dispersed by internal proctoring, might eliminate the negative effect of the learning curve on the clinical outcomes.
Methods: The present study was a retrospective, single-center, observational cohort study of prospectively collected data from all 500 consecutive high-risk patients undergoing transapical transcatheter aortic valve implantation at our institution from April 2008 to December 2011. Of the 500 patients, 28 were in cardiogenic shock. Differences during the study period in baseline characteristics, procedural and postprocedural variables, and survival were analyzed using different statistical methods, including cumulative sum charts.
Results:
The overall 30-day mortality was 4.6% (95% confidence interval, 3.1%-6.8%) and was 4.0% (95% confidence interval, 2.6%-6.2%) for patients without cardiogenic shock. Throughout the study period, no significant change was seen in the 30-day mortality (Mann-Whitney U test, P ¼ .23; logistic regression analysis, odds ratio, 0.83 per 100 patients; 95% confidence interval, 0.62-1.12; P ¼ .23). Also, no difference was seen in survival when stratified by surgeon (30-day mortality, P ¼ .92). An insignificant change was seen toward improved overall survival (hazard ratio, 0.90 per 100 patients; 95% confidence interval, 0.77-1.04; P ¼ .15).
Conclusions:
The structured training program can be used to introduce transapical transcatheter aortic valve implantation and then gradually dispersed by internal proctoring to other members of the team with no concomitant detriment to patients. (J Thorac Cardiovasc Surg 2013;145:911-8)
The pioneering centers of transcatheter aortic valve implantation (TAVI) reported an important initial negative effect of the learning curve on the clinical outcomes. [1] [2] [3] [4] [5] [6] [7] Centers that introduced a TAVI program later on, such as our institution, 8 have had the opportunity to benefit from the cumulative knowledge of the ''first wave'' centers. Therefore, ''second wave'' centers might have a different learning curve, with a lower negative effect on outcome (ie, survival).
To test this hypothesis, we conducted a single-center study of the first 500 consecutive patients undergoing transapical TAVI. We examined the factors relevant to an institutional learning curve. Subsequently, we assessed (''aim of the study'') whether the cumulative knowledge from the field incorporated into a structured training program could be used for introduction of a novel procedure (transapical TAVI) into clinical practice and then dispersed by internal proctoring to other members of the TAVI team without detriment to the clinical outcomes.
METHODS

Study Design
The present study was a retrospective, observational, single-center, cohort study of prospectively collected data from all patients who had undergone transapical TAVI at the Deutsches Herzzentrum Berlin (Berlin, Germany) from the beginning of the clinical introduction of transapical TAVI in April 2008 to December 2011. The study is reported according to the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement and the standardized endpoint definitions for TAVI clinical trials. 9 Our institutional review board approved the present study.
Patients
All 500 consecutive high-risk patients with aortic valve stenosis who underwent transapical TAVI at our institution were operated on by the same heart team and were included in the study (''study cohort''). All procedures were performed according to our structured training program and our TAVI checklist 10 (see Part 2, Table 1 ). All patients or their representatives gave informed consent.
Patient Selection and Procedural Criteria
The patient selection, preoperative evaluation, assessment of the diameter of the aortic annulus, valve size selection, and procedural technique have been previously described in detail 8, 11 and summarized as the institutional clinical policies. 10 
Procedure and Device
Transapical TAVI was performed in the hybrid operating room by the same TAVI team 8 using a principal surgical technique, 12 with some modifications, 13 according to the institutional policies. 10 The attendance of each member of the team in the hybrid operating room and his or her particular function during every procedure were precisely recorded in our database. Balloon-expandable transcatheter stent-prosthetic xenograft valves with their delivering systems (both Edwards Lifesciences LLC, Irvine, Calif) were used in all patients. The Edwards Sapien THV valves (size 23 
Structured Educational Training Program
The program 10 regulates the introduction of TAVI at our institution and the building and training of the team. It includes a stepwise acquisition of the tools necessary for preoperative strategic planning, perioperative team communication, technical aspects of the procedure, and postoperative management. The program consists of 4 main parts: general principles, team building, team education and training, and the institutional clinical and procedural policies. 10 
Proctoring
Proctoring was divided into external and internal proctoring. Internal proctoring (''self-proctoring'') was established on a basis of interaction between the members of the team (''be proctor and proctored''), with the aim of achieving a complete understanding of the fine details of the TAVI process. 10 It was performed in 4 segments: patient evaluation (segment 1); measurement of the aortic annulus and valve sizing (segment 2); valve preparation, technical procedural part, and guiding of the team (segment 3); and postprocedural patient management (segment 4). 10 
Definition of Outcomes
The primary endpoint was 30-day mortality. It was defined as death from any cause and irrespective of whether the death occurred from day 0 to day 30 (30th day included) after the index procedure.
The secondary endpoints included survival at follow-up and the intraprocedural, procedural, and postprocedural variables. Postimplantation aortic regurgitation, estimated by echocardiography and angiography, was divided (grade 0-IV) into absent (0), trace (<I), mild (I), moderate (II), and severe (>II, III, IV).
14 Technical procedural complications were considered surgical complications if they necessitated revision and were directly caused by surgical technical failure, including pseudoaneurysm of the apex, revision for bleeding, iatrogenic aortic dissection, valve migration, and annular rupture.
Follow-up and Data Collection
Follow-up was 100% complete. The most recent patients had at least 30 days of follow-up. The last update was performed in January 2012. All data concerning patient comorbidities, morbidity, and mortality were prospectively collected in an electronic database and analyzed. Information about the deaths of German patients was obtained from the official state administrative office and/or by direct contact with the patients' families and by telephone for the patients from outside Germany.
Assessment of Institutional Learning Curve
The effect of the learning curve was assessed by the procedural outcome (the incidence of complications and survival) and by the time effectiveness of the procedure (operating time duration, amount of contrast medium, irradiation parameters, intensive care unit stay, and hospitalization period).
Cumulative Sum Analysis
Data are also presented graphically as a plot of the outcome (cumulative sum analysis [CUSUM]). A cumulative failure chart 15, 16 was used to evaluate the learning curve. The cumulative sum S n of deaths until procedure n was plotted against n.
Statistical Analysis
Continuous variables are presented as the mean AE standard deviation or medians and interquartile range (IQR). Categorical variables are described as numbers and percentages. The 30-day rates during the study period are presented as percentages with 95% Wilson confidence intervals (CIs). Changes during the study period were analyzed, with the consecutive number of the procedure as an independent variable. Trends of the binary variables during the study period were compared between groups using the Mann-Whitney U test. The strength of the change was assessed by logistic regression analysis, checked by the Hosmer-Lemeshow test, and presented with the odds ratio and 95% CI. To improve readability, the odds ratios are presented for changes within 100 procedures. The trends of continuous variables were tested by nonparametric Spearman rank correlation (rho) with the number of the procedure. The Kruskal-Wallis test was used to assess the difference in the procedure time between different operators. Fisher's exact test was used to test for differences in mortality between groups and to assess the binary risk factors for mortality. The Mann-Whitney U test was used to analyze the continuous risk factors for mortality. Bivariate logistic regression analysis was applied to analyze the influence of risk factors on the learning curves of mortality. Overall survival is presented using Kaplan-Meier curves and was compared between groups using the logrank test. A change in overall survival during the study period was analyzed using Cox regression analysis and is presented as the hazard ratio per 100 procedures with the 95% CI. The data were evaluated using the IBM SPSS Statistics software, version 19 (SPSS Inc, Armonk, NY).
RESULTS
Baseline Characteristics
Patient characteristics. The study cohort consisted of 311 women (62.2%) and 189 men (37.8%). The mean patient age was 79.5 AE 8.1 years (median, 80.6 years; range, 28.9-98.9 years; IQR, 75.3-84.6 years). The median logistic European System for Cardiac Operative Risk Evaluation of the study cohort was 30.4% (IQR 21.0%-48.5%) and the median Society of Thoracic Surgeons predicted operative mortality was 12.2% (IQR, 6.7%-21.6%). Of the 500 patients, 28 (5.6%) were in cardiogenic shock. The mean follow-up period was 458 AE 368 days, with a range of 0 (in the case of death during the procedural day) to 1363 Table 1 . Edwards Sapien THV valves were used in 406 study patients (81.2%) and Edwards Sapien XT valves in 94 (18.8%). Combined planned percutaneous coronary intervention (PCI) was used in 57 patients (11.4%), and cardiopulmonary bypass (CPB) was electively used in 25 (5%). Of the 500 patients, 11 (2.2%) underwent additional combined conventional cardiac surgery. Four conversions (0.8%) were required to conventional aortic surgery (three for annular rupture). The final paravalvular or transvalvular regurgitation grade was 0.4 AE 0.5 (range, 0-2). Thirty-day mortality. The overall 30-day mortality rate for the whole study cohort of 500 patients was 4.6% (95% CI, 3.1%-6.8%), with 23 deaths among the 500 
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The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 4 913 patients (Appendix Table 2 The series of 100 patients with the greatest 30-day mortality rate during the study period was between indexed procedures 258 and 357, with mortality of 8.0% (8 of these 100 consecutive patients died). The series of 100 patients with the lowest 30-day mortality rate per 100 consecutive patients (1.0%) was found between indexed procedures 358 and 463. (In this series between indexed procedures 358 and 463, when all 105 consecutive patients were included, the mortality was 0.9%, with 1 death.) One series of 75 consecutive patients (between indexed procedure 358 and 432) had no deaths within 30 days after the index procedure (30-day mortality, 0%). No mortality occurred among the first 11 patients. The last death (indexed procedure 499) occurred intraoperatively. A total of 8 patients (1.6%) died intraoperatively. The 30-day mortality in the 5 subgroups of each 100 consecutive patients was 6%, 6%, 3%, 5%, and 3%. Changes in patient characteristics during study period. Differences in the demographic characteristics of the treated patients were seen in the percentages of men and women and the risk profile of the patients, as mirrored by the risk scores. During the study period, a significant increase occurred in the percentage of male patients (MannWhitney U test, P ¼ .002) and a reduction in the risk scores (logistic European System for Cardiac Operative Risk Evaluation, Society of Thoracic Surgeons predicted risk of mortality, Society of Thoracic Surgeons morbidity or mortality risk; Spearman rank correlation for each variable, P<.001). However, bivariate logistic regression analysis demonstrated that these changes in patient characteristics did not influence the learning curves of 30-day mortality. Procedural characteristics with no changes through study period. No significant changes were seen in the mean rates of elective PCI (P ¼ .95), elective use of CPB (P ¼ .48), and emergency use of CPB (P ¼ .62). Also, no significant changes were seen in the mean duration of the induction of anesthesia (Spearman's rho, 0.05; P ¼ .25), amount of contrast volume used per procedure (rho, 0.09; P ¼ .053), number of repeat ballooning procedures for paravalvular leakage (Mann-Whitney U test, P ¼ .38), final regurgitation grade (rho, À0.06; P ¼ . 16 Procedural characteristics with changes during study period. The procedure duration, radiation time, postoperative ventilation time, and hospital stay at our institution decreased during the study period (P<.001 for all variables). Also, a significant reduction was seen in the use of a second Edwards Sapien valve during the same procedure (P ¼ .006). Technical procedural complications during study period. The incidence of surgical complications occurring during the technical part of the procedure was very low (Table 1 ) and included revision for bleeding in 7 (1.4%; indexed procedure 17, 20, 53, 104, 282, 333, and 389), surgical revision of apical pseudoaneurysm in 2 (0.4%; indexed procedure 109 and 261), iatrogenic aortic dissection in 1 (0.2%; indexed procedure 413; treated by transapical placement of an uncovered aortic endostent; patient survived 16 ), and valve migration in 1 patient (0.2%; indexed procedure 499; patient died intraoperatively). Annular rupture occurred in 6 patients (1.2%; indexed procedure 60, 169, 259, 305, 422, and 423), with 3 deaths. 11 Because few events occurred per risk factor, the number of events was not sufficient to enable accurate statistical analysis. 18 Late survival. The overall 6-month, 1-year, and 2-year survival rate was 83.9% AE 1.7%, 80.1% AE 1.9%, and 68.4% AE 2.7%, respectively, for the whole group (Figure 2 ). An insignificant change was seen toward improved overall survival during the study period, with a 10.3% reduction in mortality per 100 procedures (hazard ratio, 0.90; 95% CI, 0.77-1.04; P ¼ .15). No differences were seen in survival when stratified by surgeon (log-rank test, P ¼ .22; Figure 2 ). Association of baseline and procedural characteristics with survival. The patients had increased 30-day mortality if they were in cardiogenic shock at surgery (P ¼ .03), if conversion to conventional valve surgery was performed (P ¼ .01), and if emergency CPB was used (P < .001).
No difference was seen in overall survival between the male and female patients (P ¼ .52; Figure 2 ), if elective PCI (P ¼ .73) or emergency PCI (P ¼ .17) was performed, if a different valve was used (THV vs XT, P ¼ .59), or if valve repeat ballooning was performed (P ¼ .13). Univariate analysis revealed that the variables age (P ¼ .13), logistic European System for Cardiac Operative Risk Evaluation score (P ¼ .12), and Society of Thoracic Surgeons predicted operative mortality score (P ¼ .14) were not conjunct with the 30-day mortality. An increased procedure duration (P <.001), radiation time (P ¼ .05), intraoperative blood and blood products given (P <.001 for packed red blood cell units and P ¼ .02 for thrombocyte units given), and postoperative fresh frozen plasma application (P < .001) were related to increased 30-day mortality. However, the EDU significant variables showed the consequence of difficulties occurring during the procedure rather than the cause of death. Owing to the small number of deaths, no multiple statistical evaluation was performed. CUSUM evaluation. The CUSUM failure graph ( Figure 3 ) showed no increase in 30-day mortality at the beginning that could be expected in a classic learning curve. 16 The chart demonstrated a cluster of deaths after indexed procedure 100, after 175, and after 300 ( Figure 3 ) that correlated with the point of a reduction in the level of internal proctoring and forced reintroduction of a greater level of internal proctoring. The Hosmer-Lemeshow test did not detect any violation of a constant odds ratio (P ¼ .60), demonstrating an adequate immediate reaction. Assessment of learning curve. The logistic learning curve (Figure 4 ) demonstrated the absence of the typical greater values (ie, absence of increased mortality) at the beginning that could be expected in a classic learning curve. 16 
DISCUSSION
The main result of the present study was the evidence that the cumulative knowledge from the field incorporated into a structured training program can be used for initial introduction of a novel technique-transapical TAVI-into clinical institutional practice and can be gradually dispersed by internal proctoring to other members of the team without negative effects on the clinical outcome. This program resulted in lower-than-expected 30-day mortality and a low technical complication rate from the beginning, remaining consistent throughout a series of 500 procedures. The negative effect of the learning curve was absent both for the whole team and individually for each surgeon. Therefore, the study results strongly recommend that a prospective TAVI team should undergo a structured and intensive training program before starting clinical application of TAVI.
An additional and important negative observation of the present study was that early mortality is increased if an intraprocedural complication occurs, requiring conversion to conventional surgery or even only institution of emergency CPB.
Cumulative Knowledge From the Field and the Learning Curve
A typical learning curve shows the ''learning phase'' at the beginning, with increased mortality or complication rate, the ''intermediate phase,'' with decreasing overall complication and mortality rates, and, finally, the ''expert phase,'' characterized by low rates. 16 In terms of mortality, 
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The Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 4 915 our learning curve missed out the first phase, which we believe to be mostly because of the structured training program that encompassed the cumulative knowledge and experience of the ''first-wave'' centers. The ''first-wave'' centers had elevated mortality during their early experience compared with their recent experience, [1] [2] [3] [4] [5] 7 and their results fit into the classic learning curve. The initial mortality during the learning curve might be double that during the expert phase. The Leipzig group 4 showed a reduction in 30-day mortality from 11.3% to 6%, comparing their first 150 patients with their subsequent 149 patients and with progressive improvement in outcomes despite an unchanged patient risk profile. It seems that each member (operator) of the team needs-in general-at least 50 to 100 procedures to reach the expert phase. Thus, the more operators/members, the longer the learning curve. However, only a few reports have been published about the ''learning curve for TAVI.'' [1] [2] [3] [4] [5] [6] [7] [8] 19 Most of them have studied, logically, only a small number of patients. The largest reported experience was of 299 patients. 4 Among the ''first-wave'' centers with extensive experience with the novel procedure (>100 procedures), the Leipzig group 4 also had the lowest 30-day mortality rate during their recent experience (6%).
Length of Our TAVI Learning Curve
The results from the present study failed to find a complete answer to this question. In terms of the primary endpoint (30-day mortality), the present study has clearly demonstrated the absence of increased mortality throughout the study period. However, in terms of the secondary endpoints, our results only gave a partially positive answer. Although the observed technical procedural complication rate was already low from the beginning of the TAVI program, the study results confirmed that a small, but certain, number of patients would-throughout the study period-have a possibly detrimental intraprocedural complication (eg, annular rupture) that is difficult to manage. This is the main disadvantage of TAVI compared with conventional aortic valve surgery. Therefore, the main problem of TAVI remains-the uncertainty about the definitive result at the end of the procedure. Similarly, it is still not possible to predict clearly whether a patient undergoing TAVI will have relevant paravalvular leakage (with known negative consequences for late survival and a reason for preferring conventional aortic valve surgery). Additionally, the effect on cognitive function of cerebral microembolization and the ischemic microlesions that always occur during all phases of valve implantation 20 remains to be defined. Therefore, we believe we are still in the learning curve. All these factors should be considered critically before the procedural indication is broadened to younger or lower risk patients.
Importance of Heart Team for Prospective Cardiovascular Training
The present study has emphasized the importance of the combined work of surgeons and cardiologists in a team. Our team was able to perform all types of TAVI procedures and conventional aortic valve surgery 21 and to treat its own procedural complications using surgical or catheter-based methods. 11, 17, 22, 23 Thus, 1 team was able to perform the procedure assessed to be the best for each patient. This attitude should have important consequences for the education and training of prospective cardiologists and surgeons. Therefore, in the future, cardiovascular training should include the knowledge, skills, and experience of both a cardiologist and a conventional cardiovascular surgeon. A prospective cardiovascular specialist should be able to perform all types of catheter-based and conventional surgery, including managing all complications using both procedures. Complications will be managed mostly using a catheter-based technique, 17, 22 with surgical revision needed only if the interventional method is not possible or fails to treat the complication.
11,23
Study Limitations
The study possessed several limitations. The main limitations were the retrospective study design and the lack of a comparable study group. However, the data were prospectively collected and timely analyzed with immediate clinical consequences. Despite this, a prospective study with a control group would make possible the comparison between proctored and nonproctored cases. Therefore, a prospective study is needed. An additional important limitation was that the device-related factors (using a modified type of valve during the experience) could have some influence (negative or positive) on the results.
CONCLUSIONS
Transapical TAVI could be a valid step toward the ultimate goal of replacing the aortic valve without surgery, but the procedure itself still needs its own learning curve. Thus, the study results strongly recommend a structured and intensive training program before starting clinical application of TAVI. 
APPENDIX
